BKM Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,929
Closed -$864K 149
2025
Q4
$864K Buy
10,929
+1,035
+10% +$81.1K 0.32% 77
2025
Q3
$791K Buy
9,894
+42
+0.4% +$3.58K 0.29% 79
2025
Q2
$896K Sell
9,852
-339
-3% -$30.9K 0.35% 76
2025
Q1
$955K Buy
10,191
+1,900
+23% +$170K 0.39% 64
2024
Q4
$754K Sell
8,291
-710
-8% -$67.8K 0.31% 81
2024
Q3
$934K Sell
9,001
-542
-6% -$55.2K 0.38% 70
2024
Q2
$926K Buy
9,543
+1,162
+14% +$107K 0.45% 68
2024
Q1
$755K Buy
8,381
+1,354
+19% +$115K 0.32% 81
2023
Q4
$560K Buy
+7,027
New +$528K 0.24% 94

Other funds holding CL

BKM Wealth Management's CL Position: Q1 2026 in Review

BKM Wealth Management sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 10,929 shares — an estimated $864K sold.

BKM Wealth Management first reported a position in CL in Q4 2023 and held it in 9 quarters. The position peaked at $955K in Q1 2025. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • BKM Wealth Management reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • BKM Wealth Management sold 10,929 Colgate-Palmolive shares in Q1 2026, an estimated $864K.
  • BKM Wealth Management first reported a position in Colgate-Palmolive in Q4 2023 and held it in 9 quarters.
  • BKM Wealth Management's Colgate-Palmolive position peaked at $955K in Q1 2025.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on BKM Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.